Best in Biotech 15 May 2023
The six most advanced microbiome players aiming for the gut
After decades of research, gut microbiome therapies are beginning to reach the market. Here are six of the companies harnessing…
- Latest Posts
Best in Biotech 12 May 2023
Five latest advancements in Tourette’s syndrome research
Named after French neurologist Georges Gilles de la Tourette, who first described the disorder in 1885, Tourette’s syndrome is estimated…
News and Trends 12 May 2023
DiogenX raises €27.5M for “breakthrough” diabetes treatment
DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, has announced the successful completion…
News and Trends 12 May 2023
Achilles Therapeutics’ new platform identifies most potent T-cell antigens
Achilles Therapeutics plc says its newly-developed AI application, trained with proprietary real-world data, outperformed current AI and non-AI methods for…
ADVERTISEMENT
News and Trends 12 May 2023
Cell and gene therapy company NewBiologix exits stealth with $50M
NewBiologix SA has emerged from stealth as a technology innovation company developing a proprietary and breakthrough platform for the advanced…
News and Trends 12 May 2023
5 highlights at first Genomics and Precision Medicine Expo
Genomics and Precision Medicine Expo – taking place on May 23 and 24 2023 at ExCeL London – has announced…
Podcast 12 May 2023
Beyond Biotech podcast 45: International MPS Awareness Day
This week’s podcast is sponsored by Quantoom. International MPS Awareness Day May is the big month when it comes to…
In Depth 11 May 2023
Battling food allergies: emerging immunotherapies
While for most individuals, picking a restaurant to dine at could simply be based on what they might be craving…
Best in Biotech 10 May 2023
5 cell therapy companies you should know about
Cell therapy has come a long way in recent years, with many biotech companies now specializing in the development of…
News and Trends 10 May 2023
Scientists create first CRISPR-based drug candidate targeting the microbiome
A new CRISPR-based drug candidate targeting E. coli in the gut microbiome is in phase 1 clinical trials. According to…
News and Trends 10 May 2023
Delivering on the need for vector innovation in genetic medicine
By Tuyen Ong, CEO Ring Therapeutics, CEO-Partner Flagship Pioneering Gene therapy is a life-changing class of medicine that can treat…
News and Trends 10 May 2023
Cell rejuvenation for age-related diseases
By Sharon Rosenzweig-Lipson, CSO, Life Biosciences Cellular rejuvenation is quickly becoming a hot topic in the development of novel therapeutic…
News and Trends 9 May 2023
The future of cell and gene therapy in hearing loss
By Nawal Ouzren, CEO of Sensorion Therapeutics for inner ear hearing loss remains an unconquered frontier and the unmet need…
Best in Biotech 9 May 2023
5 cancers that immunotherapy can cure
Cancer immunotherapy dates back to 1891, when William Coley became the first person to try and harness the immune system…
Opinion 9 May 2023
Where is innovation needed in cell therapy?
By Dr Ryan Roberts, cell processing lead at Cellular Origins Despite the rapidly emerging innovations in the field of cell…
News and Trends 9 May 2023
Gilead boosts oncology pipeline with XinThera acquisition
Gilead Sciences, Inc. has announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San…
ADVERTISEMENT
News and Trends 9 May 2023
Gene & cell therapy manufacturer Ascend launches with more than $130M
Ascend Gene & Cell Therapies (Ascend), a company innovating manufacturing processes to improve quality, potency, safety and cost enabling better…
News and Trends 9 May 2023
Ultra-long protein fibrils could help with early Alzheimer’s diagnosis
The early diagnosis and treatment of dementia such as Alzheimer's disease is still a big challenge. It is already known…
News and Trends 9 May 2023
Recursion boosts drug discovery with Cyclica and Valence acquisitions
Recursion has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica, for $40 million, and Valence,…
News and Trends 9 May 2023
Researchers overcome stem cell delivery issues
A recent study explains how researchers have devised a new method for delivering particles into stem cells, which are difficult…
